Detalhe da pesquisa
1.
Thrombotic and bleeding complications in patients with AL amyloidosis.
Br J Haematol
; 204(5): 1816-1824, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321638
2.
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome.
Br J Haematol
; 204(5): 1790-1800, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38414235
3.
Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin.
Basic Res Cardiol
; 2024 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520533
4.
Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Part 1 results of a phase I/II study.
Haematologica
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356458
5.
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA.
Am J Hematol
; 99(3): 396-407, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298023
6.
Outcomes of patients with light chain (AL) amyloidosis after failure of daratumumab-based therapy.
Br J Haematol
; 203(3): 411-415, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580907
7.
miRNA-seq identification and clinical validation of CD138+ and circulating miR-25 in treatment response of multiple myeloma.
J Transl Med
; 21(1): 245, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37024879
8.
Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies.
Eur J Haematol
; 111(2): 271-278, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218632
9.
Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing.
Am J Hematol
; 98(5): 750-759, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866925
10.
Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation.
Int J Mol Sci
; 24(18)2023 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762269
11.
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma.
Int J Mol Sci
; 24(14)2023 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511588
12.
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study.
Lancet Oncol
; 23(1): 65-76, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871550
13.
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.
Br J Cancer
; 126(1): 79-90, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34718359
14.
Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.
Br J Haematol
; 196(2): 356-359, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34528249
15.
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.
N Engl J Med
; 381(8): 727-738, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433920
16.
Comparison of MRI Features of Fat Fraction and ADC for Early Treatment Response Assessment in Participants with Multiple Myeloma.
Radiology
; 304(1): 137-144, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380497
17.
Diabetes mellitus and multiple myeloma; common features of two distinct entities.
Diabetes Metab Res Rev
; 38(5): e3535, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35555946
18.
Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist.
Am J Hematol
; 97(1): 119-128, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687462
19.
SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies.
Am J Hematol
; 97(10): 1300-1308, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35871310
20.
Chromosome 1q21 aberrations identify ultra high-risk myeloma with prognostic and clinical implications.
Am J Hematol
; 97(9): 1142-1149, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731917